Clinical applications of targeted radionuclide treatment have evolved considerably over the last 10-20 years, principally as a result of an improved understanding of tumour biology, and the identification of biochemical pathways and protein targets expressed preferentially on tumours compared to normal tissue. As a result, targeted therapy of cancer with radionuclides has evolved to include a number of therapies that have achieved success in the clinic, and a broad range of strategies that are being actively pursued in laboratory studies and clinical trials. © 2008 Springer Science+Business Media B.V.
CITATION STYLE
Scott, A. M., & Lee, S. T. (2008). Clinical radionuclide therapy. In Targeted Radionuclide Tumor Therapy: Biological Aspects (pp. 349–385). Springer Netherlands. https://doi.org/10.1007/978-1-4020-8696-0_20
Mendeley helps you to discover research relevant for your work.